Fairvalue-Calculator Fairvalue-Calculator
EN DE

Beijing Centergate Technologies (holding) Co (000931) Fair Value & Analysis

Healthcare · CN · Market cap 3.1B CNY

Price¥4.40
Fair Value¥2.54
Upside-42.3%
Quality87/100
Evidence: Medium Range ¥1.62 – ¥3.46

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Beijing Centergate Technologies (holding) Co (000931) currently trades at ¥4.40, while our model-based Fair Value estimate is ¥2.54 — implying the stock looks roughly 42.3% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of exogenous opioids; Hydrocodone acetaminophen tablets for the treatment of moderate to severe pain; Ambroxol Hydrochloride injection for acute and chronic lung diseases; Tramadol Hydrochloride injection for moderate to severe pain; Febuxostat tablets for long-term treatment of hyperuricemia; and Glipizide Dispersible tablets to improve glycemic control in adults with type 2 diabetes. It also provides Metoprolol succinate API for hypertension and coronary heart disease; Bisoprolol Fumarate tablets for chronic stable heart failure; Tropisetron Mesylate injection for prevention and treatment of …

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -62% EssilorLuxottica Société anonyme (ESLOF) -44% HOYA Corporation (HOCPY) -43% Medline Inc (MDLN) -15% Becton, Dickinson and Company (BDX) -22% Alcon Inc (ALC) -44%

Frequently asked questions

Is Beijing Centergate Technologies (holding) Co (000931) undervalued?
As of Jun 26, 2026, our model estimates a fair value of ¥2.54 versus a price of ¥4.40 — about −42% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 000931?
Our 21-model fair value for Beijing Centergate Technologies (holding) Co is ¥2.54 (as of Jun 26, 2026), built from audited fundamentals. The current price is ¥4.40.
What is the quality score of 000931?
Beijing Centergate Technologies (holding) Co has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.